International Conference onn

Pharmacoviligance and Regulatory Affairs

March 24, 2025 | Rome, Italy

  • Authors are invited to submit abstracts through the Conference Submission Systems, Click the Submit Abstract Button Below.

Submit Abstract Register Now

Scientific Board


Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacoviligance and Regulatory Affairs.


To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Pharmacoviligance and Regulatory Affairs.

Dates to remember

Abstract Submission Deadline
October 15,2024
Early Bird Registration
June 07,2024
Conference Dates
March 24, 2025

About Conference

We are pleased to announce that The International Conference on Pharmacovigilance and Regulatory Affairs will be held on March 24-26, 2025, Rome, Italy.

ICPRA 2025 will bring more interaction, stronger networking, and a deeper exchange of expertise in 2025. Field professionals will gather to listen to well-endorsed speakers talking about the 2025 updates on Pharmacovigilance and drug safety.

The main goal of the conference is to showcase the advances and challenges in pharmacovigilance and regulatory affairs , which helps assess the risks and take necessary actions and more. The conference will feature plenary and keynote lectures by eminent experts, oral and poster presentations by participants, workshops and exhibitions by sponsors and exhibitors.

Join us in the beautiful city of Rome, Italy for this conference, where we are dedicated to providing a top-notch experience that will undoubtedly be among the best you’ve ever attended.

We look forward to welcoming you to Rome for an unforgettable experience at the International Conference on pharmacovigilance and regulatory affairs!

Sai Lakshmi,Secretery

Submit Abstract Register Now

Scientific Sessions
  • Pharmacovigilance and Eudravigilance
  • Explanation of biomarker testing and its role in treatment decisions
  • Identification of Risk Factors
  • Good Drug Development Practices
  • Post-marketing surveillance
  • Big data and AI in pharmacovigilance
  • Drug legislation and regulations
  • Benefit-risk management strategies
  • Concept of drug safety
  • Importance of HIV testing for early detection
Scientific Sessions
  • Adverse drug Reactions Reporting
  • Harmonization and pharmaceutics
  • Innovative approaches to drug safety
  • PV Regulations and Challenges
  • Medical Devices Safety
  • Adverse Drug Reactions
  • Big data and AI in Drug Surveillance
  • Patient Centric Drug Safety
  • Drug Testing Workflows with AI & Automation
  • Safety Signals & Management

Previous Glimpses

Need help now? Mail us now:

Book your Speaker or Delegate slot. Contact us regarding group registrations on special prices